• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 17

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Maintain timeliness of payments to vendors per HHS mandatesOPERATIONSOffice of Finance, Budget, and AcquisitionN/AN/A
2Maintain compliance with the Department of Treasury and HHS' policies and strategies for managing FDA's accounts receivablesOPERATIONSOffice of Finance, Budget, and AcquisitionN/AN/A
3Monitor contracts awarded to small businesses to ensure annual targets are metOPERATIONSOffice of Finance, Budget, and AcquisitionN/AN/A
4Monitor contracts competed over the micro-purchase threshold ($3K) to ensure HHS mandates are metOPERATIONSOffice of Finance, Budget, and AcquisitionN/AN/A
5Establish Data Management SystemOPERATIONSEmployee Safety and Environmental ManagementN/AN/A
6Consolidation of Life Sciences-Biodefense Complex to White OakOPERATIONSOffice of Facilities, Engineering, and Mission Support ServicesN/AN/A
7Maintain number of Personal Identification Verification (PIV) Cards issued annuallyOPERATIONSOffice of Security OperationsN/AN/A
8Discrimination complaint timeliness measures OPERATIONSOffice of Equal Employment OpportunityN/AN/A
9Promote equality, fairness, understanding and acceptance of diversity at the FDAOPERATIONSOffice of Equal Employment OpportunityN/AN/A
10Diversity Council Enhancement ProjectOPERATIONSOffice of Equal Employment OpportunityN/AN/A
11Ensure 90% of all FDA Information Systems have a valid Authority to Operate (ATO) for the fiscal yearOPERATIONSOffice of Information Management and TechnologyN/AN/A
12OpenFDAOPERATIONSOffice of Information Management and TechnologyN/AN/A
13Total number of emergency preparedness exercises which FDA participated in planning, executing, or evaluating during the monthOPERATIONSOffice of Crisis ManagementOCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response
14Cumulative number of emergency preparedness exercises in which FDA participates in during the fiscal yearOPERATIONSOffice of Crisis ManagementOCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response
15Cumulative percentage of employees who are identified to take ICS 300 in the current FY who have completed their trainingOPERATIONSOffice of Crisis ManagementOCM Strategic PlanAssist in the development, management, and coordination of incident management policies and programs for FDA to ensure that an agency structure exists to respond rapidly and effectively to all hazards
16Number of incidents involving FDA-regulated products that are coordinated by the Office of Emergency Operations (OEO) during the monthOPERATIONSOffice of Crisis ManagementOCM Strategic PlanServe as the FDA's focal point for coordinating emergency and crisis response activities involving FDA regulated products
17Establishment of FDA Emergency Task ForceOPERATIONSOffice of Crisis ManagementOCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.